“Successfully commercialising bacteriophage-based products hinges on a multidimensional strategy. “Forging partnerships and collaborations, particularly between academic institutions and biotech firms, can accelerate research, bolster resources and improve market credibility.” In our blog, ‘Success in Bacteriophage Commercialisation: Key Considerations,’ we explore industry advancements, regulatory hurdles and essential approaches for bringing bacteriophage products to market. 🧫 Discover how biotech companies – like ours – are driving the future of bacteriophage commercialisation, addressing the critical need for alternative treatments in the face of rising antibiotic resistance. Visit our website to learn more. #Bacteriophage #AMR #Innovation #Phage
NexaBiome
Biotechnology Research
Glasgow, Scotland 2,840 followers
Targeted phage technology, safeguarding human and animal health by harnessing sustainable, antibacterial technology
Über uns
NexaBiome's patented technology enables bacteriophages to be covalently attached to a wide variety of substrates; this gives them enhanced stability for use in a variety of applications which address two of the world's major challenges, antibiotic resistance and food supply and sustainability. By attaching specific bacteriophages to fish and animal feeds, we can reduce, augment or even substitute for antibiotics in the food chain. This lets us target both human and animal pathogens, such as E. coli, Listeria, Campylobacter, Salmonella, Streptococcus, Pseudomonas, Flavobacteria and others. As our bonded phage products can be stable for months or even years and are less sensitive to temperature and other environmental factors, they can be effectively shipped and applied in versatile formulations Bacteriophages also have many potential human applications when antibiotics fail. Phages are expert microbiome engineers and can specifically alter the bacterial microbiome of the human gut, skin, vagina, lung and other micro-environments. Microbiome engineering has important applications to irritable bowel syndrome, acne, bacterial vaginosis and bacterial lung diseases. Our ability to attach bacteriophages to micro- and nano-particles and to enhance their stability and active life span, can potentially enhance their effectiveness in these applications, whether as part of a probiotic supplement or as encapsulated powders/beads.
- Website
-
https://nexabiome.com/
External link for NexaBiome
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Glasgow, Scotland
- Typ
- In Privatbesitz
- Gegründet
- 2010
- Spezialitäten
- Probiotic Feeds, Antibiotic Resistance, Food Wastage, Zinc Oxide Replacement, Formaldehyde Replacement, Aquaculture, Poultry, Microbiome, Active Packaging, Veterinary Health, Tilapia, Salmonids, Shelf Life Extension, AgriScience, MRSA, E.coli, Pseudomonas, Campylobacter, and Listeria
Standorte
-
Primäre
2317 Maryhill Road
Block 2 Units 1&2
Glasgow, Scotland G20 0SP, GB
Employees at NexaBiome
Aktualisierungen
-
We’re on a mission to tackle AMR with sustainable phage-based solutions. 🌍 🔬 With over a decade of expertise in phage discovery, development and manufacturing, we’re your trusted partner in the fight against this global threat. Our journey began at Strathclyde University, where a breakthrough led to the development of a bacteria-free container. This innovation paved the way for our advanced phage applications today. 🧪 Our patented technology allows phages to irreversibly bind to almost any surface, ensuring stability and effectiveness against specific bacteria for years, rather than days. #AMR #PhageTherapy #Bacteriophage #Sustainability #Microbials
-
-
A phage’s DNA is encased in a capsid – a type of protein shell. 🧬 The capsid serves several critical functions, including: 🔹Protection – safeguarding the viral genetic material from enzymes and other environmental factors. 🔹Delivery – the capsid facilitates the delivery of the phage's genetic material into host cells using its tail fibres and spikes. 🔹Host specificity – it determines the host range and specificity of the virus by recognising and binding to specific receptors on the surface of target bacteria. #Bacteriophage #Phage #DNA #Science
-
-
Could climate change be pushing us closer to a pre-antibiotic era? 🌡️ This article, published by Salon Media Group, Inc. reports on the concerning impact extreme heat is having on AMR. Not only does the warmer weather increase the reproduction rates of bacteria, but one study revealed common pathogens, like E. coli, became more resistant to treatment. Another compelling reason why we must develop innovative and sustainable phage-based treatments. Read the full article below. 🔗👇 #ClimateChange #AMR #Antibiotics
-
-
AMR is a major threat to us all, with drug-resistant infections expected to cause an estimated 10 million deaths annually by 2050. ⚠️ The solution? A targeted, collaborative approach, embracing alternative treatments such as phage therapy. 💉 We’re committed to developing comprehensive and effective phage solutions for hard-to-treat infections. Our expertise in phage isolation and selection, combined with our patented formulation technology, enables us to cultivate phages through a batch process – paving the way for large-scale manufacturing. 🌐 Discover more on our website. #PhageTherapy #AMR #Bacteriophage #Health
-
-
Phages are highly specific to their bacterial hosts, making them a powerful tool against infections without disrupting beneficial bacteria. 🌟 Phage therapy precisely targets harmful bacteria while leaving our microflora intact -unlike antibiotics. 🎯 That's why phages are known as precision warriors in the fight against AMR. #PhageTherapy #GutHealth #Bacteriophage #AMR
-
-
This is interesting… Researchers have designed a high throughput phage screening platform for rapid target identification in personalised phage therapy. This innovative technology significantly improves the efficiency of identifying bacteriophages that can combat antibiotic-resistant superbugs. The study has been published in Nature. Have a read it and let us know your thoughts. 🔗👇 #PhageTherapy #Bacteriophage #AMR
-
-
The world risks returning to a pre-antibiotic era as bacteria become increasingly resistant to drugs. 🦠 Phages are being harnessed to combat this threat, with their antimicrobial power making them effective tools against harmful pathogens. 🔬 Our patented formulation technology allows us to develop phage-based treatments at mass scale, meaning millions of lives could be saved each year. Through extensive scientific research and discovery, we are determined to win this fight against AMR. #Bacteriophage #PhageTherapy #AMR #Science
-
-
Did you know, phages aren’t motile and they move only through random Brownian motion or fluid dynamics? Despite this, they skilfully capture moving bacteria using their spiked tail fibres, latching onto the host cell before injecting their genetic material. Essentially, they’re always on standby, ready to target their next bacterial victim! 🦠🔬 #Bacteria #Bacteriophage #Science
-
-
We are committed to pursuing scientific excellence through a culture of innovation – with the needs of the patient front and centre. ✨ Just some of the core values that lie at the heart of our mission here at NexaBiome. We commit to upholding the highest standards in research and development to ensure that our phage-based solutions are backed by robust scientific evidence and underpinned by integrity and transparency. Just as important is the environment that we work in, our dedicated team celebrates diversity in all its forms and we are committed to creating an inclusive workplace where every voice is valued and heard. 🙌 Together, we can shape a healthier future for all. #PhageTherapy #Science #AMR #Bacteriophage
-